Windlas Biotech Ltd.

NSE: WINDLAS | BSE: 543329 | ISIN: INE0H5O01029 | Industry: Pharmaceuticals
| Mid-range Performer

830.90
-0.97%
Prabhudas Lilladhar
experience in manufacturing (solid/ liquid) multiple dosage offers a comprehensive range of CDMO services in India. Over time Windlas evolved and 6) strong financial performance with experienced management. It owns...
Windlas Biotech Ltd. average weekly volume is high.
More from Windlas Biotech Ltd.
Recommended